scholarly journals The Role of Minimally Invasive Surgery in the Treatment of Lung Cancer

2021 ◽  
Author(s):  
Güntuğ Batihan ◽  
Kenan Can Ceylan
Keyword(s):  
Lung Cancer ◽  
Minimally Invasive ◽  
Early Stage ◽  
Locally Advanced ◽  
Length Of Hospital Stay ◽  
Vats Lobectomy ◽  
Early Stage Lung Cancer ◽  
Oncologic Results ◽  
Stage Lung Cancer

Lobectomy plus regional lymph node dissection remains the gold standard treatment method in early-stage lung cancer. However, with the demonstration of the safety and efficacy of minimally invasive approaches, the expression of surgery in this statement, replaced by thoracoscopic anatomical lung resection. Clinical studies have demonstrated the superiority of VATS in terms of postoperative pain, drainage time, length of hospital stay, and complications, moreover, long-term oncologic results are similar or better than thoracotomy. Therefore, VATS lobectomy is the preferred surgical method in early-stage lung cancer. Different surgical techniques are available in VATS and can be modified according to the surgeon’s personal experience. Uniport can be applied as well as two or three port incisions. In this book section, I plan to focus on VATS lobectomy, technique-related tricks, complication management, and long-term oncologic results in early and locally advanced lung cancer.

VATS and Minimally Invasive Resection in Early-Stage NSCLC

2020 ◽  
Vol 41 (03) ◽  
pp. 335-345
Author(s):  
Hai Salfity ◽  
Betty C. Tong
Keyword(s):  
Lung Cancer ◽  
Minimally Invasive ◽  
Early Stage ◽  
Locally Advanced ◽  
Lung Parenchyma ◽  
Vats Lobectomy ◽  
Early Stage Lung Cancer ◽  
Early Stage Disease ◽  
Hilar Lymph Node ◽  
Thoracoscopic Lobectomy

AbstractLung carcinoma widely affects men and women in the sixth and seventh decades of life. Thorough workup with radiographic imaging, pathologic diagnosis, and cardiopulmonary functional assessment is key to successful treatment. Accurate staging is essential for both assessing prognosis and directing therapy. Early-stage lung cancer is most often treated with anatomic lobectomy; locally advanced cancers may require induction or adjuvant therapies. Any nonnodal metastases will require definitive systemic therapy. Traditionally, surgery was performed with a posterolateral thoracotomy incision, division of the hilar vessels, removal of affected lung parenchyma, and a complete mediastinal and hilar lymph node dissection for accurate pathologic staging. In recent years, however, video-assisted thoracoscopic (VATS) or other minimally invasive approaches have emerged as the standard of care for early-stage disease. Compared with standard thoracotomy, VATS lobectomy offers improved postoperative outcomes as well as potential survival benefit. Thoracoscopic lobectomy is also cost-effective. This article focuses on the technique, outcomes, adaptation, and evolution of thoracoscopic lobectomy and other minimally invasive techniques in the treatment of lung cancer.

Do minimally invasive approaches increase the survival of patients with early-stage lung cancer undergoing lobectomy

2016 ◽  
Vol 1 ◽  
pp. 18-18
Author(s):  
Benoît Bédat ◽  
Wolfram Karenovics ◽  
Samira Mercedes Sadowski ◽  
Frédéric Triponez
Keyword(s):  
Lung Cancer ◽  
Minimally Invasive ◽  
Early Stage ◽  
Early Stage Lung Cancer ◽  
Stage Lung Cancer

scholarly journals VATS lobectomy vs. open lobectomy for early-stage lung cancer: an endless question—are we close to a definite answer?

2019 ◽  
Vol 11 (12) ◽  
pp. 5616-5618 ◽  
Author(s):  
Francesco Guerrera ◽  
Anne Olland ◽  
Enrico Ruffini ◽  
Pierre-Emmanuel Falcoz
Keyword(s):  
Lung Cancer ◽  
Early Stage ◽  
Vats Lobectomy ◽  
Early Stage Lung Cancer ◽  
Definite Answer ◽  
Open Lobectomy ◽  
Stage Lung Cancer

scholarly journals Tumor-node-metastasis staging and treatment patterns of 73,167 patients with lung cancer in Brazil

2020 ◽  
Vol 46 (1) ◽  
Author(s):  
Guilherme Jorge Costa ◽  
Maria Júlia Gonçalves de Mello ◽  
Anke Bergmann ◽  
Carlos Gil Ferreira ◽  
Luiz Claudio Santos Thuler
Keyword(s):  
Lung Cancer ◽  
Cell Carcinoma ◽  
Early Stage ◽  
Locally Advanced ◽  
Sao Paulo ◽  
Treatment Patterns ◽  
São Paulo ◽  
Early Stage Lung Cancer ◽  
The City ◽  
Stage Lung Cancer

ABSTRACT Objective: To characterize the clinical and histological profile, as well as treatment patterns, of patients with early-stage, locally advanced (LA), or advanced/metastatic (AM) lung cancer, diagnosed between 2000 and 2014, in Brazil. Methods: This was an analytical cross-sectional epidemiological study employing data obtained for the 2000-2014 period from the hospital cancer registries of two institutions in Brazil: the José Alencar Gomes da Silva National Cancer Institute, in the city of Rio de Janeiro; and the São Paulo Cancer Center Foundation, in the city of São Paulo. Results: We reviewed the data related to 73,167 patients with lung cancer. The proportions of patients with early-stage, LA, and AM lung cancer were 13.3%, 33.2%, and 53.4%, respectively. The patients with early-stage lung cancer were older and were most likely to receive a histological diagnosis of adenocarcinoma; the proportion of patients with early-stage lung cancer remained stable throughout the study period. In those with LA lung cancer, squamous cell carcinoma predominated, and the proportion of patients with LA lung cancer decreased significantly over the period analyzed. Those with AM lung cancer were younger and were most likely to have adenocarcinoma; the proportion of patients with AM lung cancer increased significantly during the study period. Small cell carcinoma accounted for 9.2% of all cases. In our patient sample, the main treatment modality was chemotherapy. Conclusions: It is noteworthy that the frequency of AM lung cancer increased significantly during the study period, whereas that of LA lung cancer decreased significantly and that of early-stage lung cancer remained stable. Cancer treatment patterns, by stage, were in accordance with international guidelines.

Sign in / Sign up

Export Citation Format

Share Document